Only Available for International Sale. Not sold in the United States.
Levothyroxine Sodium Tablets
Provides thyroid hormone replacement therapy in all conditions of inadequate production of thyroid hormones in dogs.
Each tablet contains the active ingredient:
|Levothyroxine Sodium, USP||0.1 – 1.0 mg (in 0.1 mg increments)|
Why choose ThyroKare™ tablets?
Formulation minimizes product degradation
Thyroid hormones, including levothyroxine sodium (T4), share the challenge of maintaining potency throughout stated shelf life. Product potency is decreased by moisture, light, heat, and carbohydrates (e.g., lactose, sucrose, dextrose, and starch) commonly used as filler. Therefore, it is important to exclude the use of fillers to enhance the stability of T4 tablets. Neogen's formulation minimizes product degradation.
Other factors such as particle size, granulation process, disintegrate selection, selection of active ingredient synthesis and source, excipients, and other proprietary data are used to provide a T4 product that offers optimum stability and reliability.
|09100||0.1 mg, 180 Tablets||℞|
|09101||0.1 mg, 1,000 Tablets||℞|
|09102||0.2 mg, 180 Tablets||℞|
|09103||0.2 mg, 1,000 Tablets||℞|
|09104||0.3 mg, 180 Tablets||℞|
|09105||0.3 mg, 1,000 Tablets||℞|
|09106||0.4 mg, 180 Tablets||℞|
|09107||0.4 mg, 1,000 Tablets||℞|
|09108||0.5 mg, 180 Tablets||℞|
|09109||0.5 mg, 1,000 Tablets||℞|
|09110||0.6 mg, 180 Tablets||℞|
|09111||0.6 mg, 1,000 Tablets||℞|
|09112||0.7 mg, 180 Tablets||℞|
|09113||0.7 mg, 1,000 Tablets||℞|
|09114||0.8 mg, 180 Tablets||℞|
|09115||0.8 mg, 1,000 Tablets||℞|
|09126||1.0 mg, 1,000 Tablets||℞|